Matthias Stelljes

Also affiliated with University Hospital Münster, Klinik für Schlafmedizin

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Efficacy and safety of extended duration letermovir prophylaxis in recipients of haematopoietic stem-cell transplantation at risk of cytomegalovirus infection: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial”.

Efficacy and safety of extended duration letermovir prophylaxis in recipients of haematopoietic stem-cell transplantation at risk of cytomegalovirus infection: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial

The Lancet Haematology(2023)10.1016/s2352-3026(23)00344-7

N/A

2.7DataRank · unranked

106 citations

Michael Henry Schmitt, Sylvain Pilorge, Matthias Stelljes, Toshiro Kawakita, Valerie Teal +5 more

Anti-CD3/CD7 immunoconjugate (T-Guard) for severe, steroid-refractory GVHD: final report of BMT CTN 2002

Bone Marrow Transplantation(2023)10.1038/s41409-023-02110-4

N/A

0DataRank · unranked

3 citations

Mehdi Hamadani, Michael J. Martens, Haris Ali, Patrice Chevallier, Hannah Choe +20 more